Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
World is currently facing a twin epidemic of obesity and type 2 diabetes in young people

World is currently facing a twin epidemic of obesity and type 2 diabetes in young people

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Combination treatment may help type 2 diabetes patients

Combination treatment may help type 2 diabetes patients

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Study of three treatments of type 2 diabetes in children and teens has begun in US

Study of three treatments of type 2 diabetes in children and teens has begun in US

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.